2005
DOI: 10.1016/j.jaad.2004.11.020
|View full text |Cite
|
Sign up to set email alerts
|

Transverse melanonychia secondary to total skin electron beam therapy: A report of 3 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 13 publications
0
12
0
Order By: Relevance
“…Iatrogenic causes of melanocytic activation include medications (especially chemotherapeutic agents) [17–19], phototherapy, X-ray exposure, and electron beam therapy [20] (Figure 3, Table 2) [2]. Presentations of iatrogenically-induced melanonychia may vary significantly depending on the exposure, but are usually associated with melanonychia of several fingernails and toenails [2].…”
Section: Melanonychiamentioning
confidence: 99%
See 1 more Smart Citation
“…Iatrogenic causes of melanocytic activation include medications (especially chemotherapeutic agents) [17–19], phototherapy, X-ray exposure, and electron beam therapy [20] (Figure 3, Table 2) [2]. Presentations of iatrogenically-induced melanonychia may vary significantly depending on the exposure, but are usually associated with melanonychia of several fingernails and toenails [2].…”
Section: Melanonychiamentioning
confidence: 99%
“…Transverse melanonychia has occurred in conjunction with use of the following: electron beam therapy [20], conventional radiographic therapy to treat hand dermatitis (used in the 1950s and 1960s) [21, 22], psoralen with ultraviolet A (PUVA) [2326], infliximab [27], zidovudine [28], prolonged antimalarial therapy with amodiaquine, chloroquine, mepacrine, or quinacrine [2, 26, 28], and chemotherapy with agents such as doxorubicin, bleomycin, cyclophosphamide, daunorubicin, dacarbazine, 5-fluorouracil, methotrexate [20], and hydroxyurea [26, 29, 30]. Transverse melanonychia associated with electron beam therapy and PUVA is benign and typically resolves with the cessation of treatment [20, 23, 26]. Interestingly, for antimalarials amodiaquine, chloroquine, and mepacrine, transverse melanonychia may be attributable to either melanin production or more commonly ferric dyschromia [2].…”
Section: Melanonychiamentioning
confidence: 99%
“…Certain diseases like Addison's disease, Albright syndrome, lichen planus, drugs, cyanocobalamine deficiency, and AIDS are commonly accompanied by cutaneous and mucosal pigmentation. [1,6] Medications (especially chemotherapeutic agents), [7,8] phototherapy, X-ray exposure, and electron beam therapy [1,9] Are the important causes of iatrogenically induced melanonychia. Syndrome-associated melanonychia, which occurs in conjunction with Laugier-Hunziker, Peutz-Jeghers, and Touraine syndromes, typically involves multiple digits, and also mucosal pigmented macules involving the lips and oral cavity.…”
Section: Discussionmentioning
confidence: 99%
“…We find this unique observation of acquired polydactylous LM as a side effect of TSEBT important for physicians to understand. There is a single report of 3 cases of transverse melanonychia on multiple fingernails following TSEBT for mycosis fungoides (1 African-American, 2 Caucasian) where the pigmentation was displaced outwards as the nails grew [2]. However, this is the first case of LM seen after TSEBT for cutaneous T-cell lymphoma (CTCL).…”
Section: Figmentioning
confidence: 99%